Insights

Expansion into Asia Leap Therapeutics is actively developing DKN-01 in Asia through an agreement with BeiGene, Ltd., presenting an opportunity to explore potential collaborations and partnerships in the Asian market.

Recent Acquisition With the acquisition of Flame Biosciences, Leap Therapeutics has expanded its portfolio, creating opportunities to introduce new products to existing clients and potentially tap into Flame Biosciences' customer base.

Participation in Healthcare Conference By participating in the J.P. Morgan Healthcare Conference, Leap Therapeutics demonstrated its commitment to networking and visibility, suggesting potential leads and connections within the biotechnology and healthcare industry.

Funding and Financials With a funding of $40M and revenue ranging from $0 - 10M, Leap Therapeutics shows financial stability, indicating potential for sales growth and investment opportunities.

Key Personnel Appointment The appointment of Monica Bertagnolli, MD, as the Director of the National Cancer Institute by the Biden administration highlights Leap Therapeutics' strong leadership network, offering potential avenues for strategic partnerships and collaborations in the healthcare sector.

Similar companies to Leap Therapeutics

Leap Therapeutics Tech Stack

Leap Therapeutics uses 8 technology products and services including Microsoft Excel, RequireJS, Prototype, and more. Explore Leap Therapeutics's tech stack below.

  • Microsoft Excel
    Editors
  • RequireJS
    Javascript Frameworks
  • Prototype
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • HSTS
    Security
  • Adobe Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

Leap Therapeutics's Email Address Formats

Leap Therapeutics uses at least 1 format(s):
Leap Therapeutics Email FormatsExamplePercentage
FLast@leaptx.comJDoe@leaptx.com
49%
Last@leaptx.comDoe@leaptx.com
2%
FLast@leaptx.comJDoe@leaptx.com
49%

Frequently Asked Questions

Where is Leap Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Leap Therapeutics's main headquarters is located at 47 Thorndike St, Suite B1-1 Cambridge, MA 02141 US. The company has employees across 2 continents, including North AmericaEurope.

What is Leap Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Leap Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Leap Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Leap Therapeutics is a publicly traded company; the company's stock symbol is LPTX.

What is Leap Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Leap Therapeutics's official website is leaptx.com and has social profiles on LinkedIn.

How much revenue does Leap Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Leap Therapeutics's annual revenue reached $7.5M.

What is Leap Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Leap Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Leap Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Leap Therapeutics has approximately 52 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: D. O.Chief Scientific Officer: J. B.Chief Medical Officer: C. S.. Explore Leap Therapeutics's employee directory with LeadIQ.

What industry does Leap Therapeutics belong to?

Minus sign iconPlus sign icon
Leap Therapeutics operates in the Biotechnology Research industry.

What technology does Leap Therapeutics use?

Minus sign iconPlus sign icon
Leap Therapeutics's tech stack includes Microsoft ExcelRequireJSPrototypejQueryOpen GraphHSTSAdobe Tag ManagerBootstrap.

What is Leap Therapeutics's email format?

Minus sign iconPlus sign icon
Leap Therapeutics's email format typically follows the pattern of . Find more Leap Therapeutics email formats with LeadIQ.

How much funding has Leap Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Leap Therapeutics has raised $40M in funding. The last funding round occurred on Apr 10, 2024 for $40M.
Leap Therapeutics

Leap Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.

Section iconCompany Overview

Headquarters
47 Thorndike St, Suite B1-1 Cambridge, MA 02141 US
Phone number
Website
leaptx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LPTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $40M

    Leap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.

  • $10M

    Leap Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $40M

    Leap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.

  • $10M

    Leap Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.